Activation of the MET signaling pathway may play a role in NET proliferation, and preclinical models suggest that combined anti-VEGF and anti-MET inhibition may enhance the inhibition of angiogenesis, tumor invasion, and metastasis [44]. Here, MET is linked to neoplasm.